In all the enrolled studies, age was an independent covariate influencing the dose-response association between ALT activity and all-cause, CV disease-related, and cancer-related mortality with a moderate but consistent impact in meta-regression analysis (Figure 3). This evidence concerns the gene GPT and cancer.